Khisimuzi E Mdluli Selected Research

TBA-354

1/2015

Contribution of the nitroimidazoles PA-824 and TBA-354 to the activity of novel regimens in murine models of tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Khisimuzi E Mdluli Research Topics

Disease

7	Tuberculosis (Tuberculoses) 01/2016 - 04/2011
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 08/2013 - 12/2011
2	Granuloma 08/2013 - 08/2012
2	Infections 08/2013 - 08/2012
2	Body Weight (Weight, Body) 08/2012 - 07/2012

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2015 - 04/2011
4	Pyrazinamide FDA LinkGeneric 08/2013 - 12/2011
3	pretomanidIBA 01/2016 - 12/2011
3	Rifampin (Rifampicin)FDA LinkGeneric 08/2013 - 07/2012
3	Isoniazid (Ftivazide)FDA LinkGeneric 08/2013 - 07/2012
2	bedaquiline (R207910)IBA 01/2016 - 12/2011
2	Drug CombinationsIBA 08/2013 - 04/2011
2	RifamycinsIBA 08/2013 - 07/2012
2	rifapentine (Priftin)FDA Link 08/2012 - 07/2012
2	FluoroquinolonesIBA 12/2011 - 04/2011
1	Oxazolidinones (2 Oxazolidone)IBA 01/2016
1	TBA-354IBA 01/2015
1	NitroimidazolesIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2013
1	AerosolsIBA 08/2013
1	Ethambutol (Myambutol)FDA LinkGeneric 08/2012
1	7- (7- amino- 7- methyl- 5- azaspiro(2.4)heptan- 5- yl)- 6- fluoro- 1- (2- fluoro- 1- cyclopropyl)- 1,4- dihydro- 8- methoxy- 4- oxo- 3- quinolinecarboxylic acidIBA 04/2011

Therapy/Procedure

2	Duration of Therapy 08/2012 - 12/2011